NeuroLeap
PrivateLast Round
Accelerator
Jan 10, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroLeap is a health technology company that provides brain assessment and enhancement services using non-invasive brain-computer interface technology.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Healthcare Analytics
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroLeap Comparables
Compare NeuroLeap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peak Brain Institute | 82% | |
| Sens.ai Incorporated | 72% | |
| PankhTech India Private Limited | 68% | |
NeuroLeap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 10, 2022 | ||||
| Angel | Oct 9, 2019 |
NeuroLeap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| N. S. Raghavan Centre for Entrepreneurial Learning | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 214% MoM, reaching 4.4K.
- May 16, 2026
Monthly visitors increased 31% MoM.
NeuroLeap Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroLeap's valuation, stock price, and market status.